Zhejiang Xianju Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VECURONIUM BROMIDE, with a corresponding US DMF Number 12050.
Remarkably, this DMF maintains an Active status since its submission on July 23, 1996, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2013, and payment made on September 16, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II